Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
M2Bio Sciences, Inc. logo — M2Bio Sciences is a pioneering nutraceutical biotech company...

M2Bio Sciences, Inc.

M2Bio Sciences is a pioneering nutraceutical biotech company. Trading on the OTC: $MRES

Founded 2018 South Africa South Africa 12 employees Post-IPO Equity Total: $450.00K Biotechnology, Health Care

General Information

Company Name M2Bio Sciences, Inc.
Founded Year 2018
Location South Africa South Africa
Employees 12
Industries Biotechnology, Health Care
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with M2Bio Sciences, Inc.. To contact M2Bio Sciences, Inc., visit m2bio.co.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does M2Bio Sciences, Inc. compare?

A PDF of M2Bio Sciences, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting M2Bio Sciences, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About M2Bio Sciences, Inc.

M2Bio Sciences, Inc. is a pioneering nutraceutical biotech company traded on the OTC under the symbol $MRES. Founded in 1988 and headquartered in South Africa, the company focuses on innovative plant-based medicines, healthy food products, and sustainable packaging solutions. M2Bio Sciences operates with a divisional structure, each dedicated to specific wellness and sustainability aspects. The company's commitment to improving human health and environmental sustainability is highlighted through its ethically and sustainably sourced products. Applying cutting-edge artificial intelligence to drive its endeavors, M2Bio Sciences received a $450.00K post-IPO equity investment on December 30, 2020 from ThreeD Capital.

Business keywords: nutraceutical biotechnology, CBD-based products, medicinal cannabis, psilocybin new therapies, botanical-based medicine, biotech research, cannabis market, medicinal mushrooms, OTC trading, mental illness treatment, Alzheimer's therapy, Parkinson's therapy, medicinal plant science, global market growth, business values

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $450.00K 1
ThreeD Capital
ThreeD Capital
30 Dec 2020

M2Bio Sciences, Inc. Alternatives & Competitors

View All Alternatives
M2Bio Sciences, Inc. vs
PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals, Inc. United States

Harnessing the power of p53 to treat cancer

Series D
70 employees
Biopharma, Biotechnology
M2Bio Sciences, Inc. vs
ALPS Group Inc.
ALPS Group Inc. Malaysia

The ALPS Group Inc. (ALPS) Group of companies, is a fully-integrated biotechnology research, medical...

Series B
34 employees
Biotechnology, Health Care
M2Bio Sciences, Inc. vs
Zelira Therapeutics
Zelira Therapeutics Australia

Zelira Therapeutics (formerly Zelda Therapeutics) is a leading global therapeutic medicinal cannabis...

Post-IPO Equity
12 employees
Biotechnology, Health Care
View all alternatives

FAQ About M2Bio Sciences, Inc.

M2Bio Sciences is a pioneering nutraceutical biotech company. Trading on the OTC: $MRES
M2Bio Sciences, Inc. was founded in 2018.
M2Bio Sciences, Inc. is headquartered in South Africa.
M2Bio Sciences, Inc. operates in Biotechnology and Health Care. Its work centres on nutraceutical biotechnology, CBD-based products, medicinal cannabis and psilocybin new therapies.
M2Bio Sciences, Inc. has approximately 12 employees.
M2Bio Sciences, Inc. has completed 1 funding round, raising a total of $450.00K. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to M2Bio Sciences, Inc. include PMV Pharmaceuticals, Inc., ALPS Group Inc., Zelira Therapeutics, Alavita, ChyloCure. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
M2Bio Sciences, Inc. and PMV Pharmaceuticals, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for M2Bio Sciences, Inc., https://bouncewatch.com/company/m2bio-sciences-inc, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes